Overview
The International Association for the Study of Lung Cancer Staging Committee recently unveiled the ninth edition of TNM staging system for lung cancer. This study aims to explore survival outcomes, stage grouping, and gene mutations in N descriptors of this new classification system.
Eligibility
Inclusion Criteria:
Pathological N2.
Exclusion Criteria:
Patients undergoing neoadjuvant chemotherapy